Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hepatitis C virus infection in special groups.

F Zoulim1

  • 1Hôtel Dieu Hospital, and Hepatitis Research Unit INSERM 271, Lyon, France. zoulim@lyon151.inserm.fr

Journal of Hepatology
|January 6, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Individual mHLA-DR trajectories in the ICU as predictors of early infections following liver transplantation: a prospective observational study.

Critical care (London, England)·2025
Same author

Benefit of direct-acting antiviral therapy for hepatitis C virus (HCV) in monoinfected and HIV-HCV-coinfected patients with mixed cryoglobulinaemia.

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases·2018
Same author

Precore G1896A mutation is associated with reduced rates of HBsAg seroclearance in treated HIV hepatitis B virus co-infected patients from Western Africa.

Journal of viral hepatitis·2018
Same author

The negative impact of HBV/HCV coinfection on cirrhosis and its consequences.

Alimentary pharmacology & therapeutics·2017
Same author

Reciprocal antagonism between the netrin-1 receptor uncoordinated-phenotype-5A (UNC5A) and the hepatitis C virus.

Oncogene·2017
Same author

Implementation of an in-house quantitative real-time polymerase chain reaction method for Hepatitis B virus quantification in West African countries.

Journal of viral hepatitis·2016
Same journal

Durvalumab with gemcitabine-based chemotherapy regimens in advanced biliary tract cancer: primary results from the phase IIIb TOURMALINE study.

Journal of hepatology·2026
Same journal

Reply to "Role of HBV genotype, monitoring, and events after cessation of nucleos(t)ide analogue therapy".

Journal of hepatology·2026
Same journal

When Biology Pushes Back: Lessons From HBsAg-Targeting Therapies in Hepatitis Delta.

Journal of hepatology·2026
Same journal

Moving Too Fast? A Meta-Analysis Calls for Caution on TNF Inhibitors as First-Line Therapy for Autoimmune Hepatitis.

Journal of hepatology·2026
Same journal

Anserine restores antibacterial immunity in cirrhosis via a protective CCL5-mediated hepatocyte-CD44<sup>+</sup>pDC crosstalk.

Journal of hepatology·2026
Same journal

Anti-CCL2-conjugated platelets attenuate early allograft and ischemia-reperfusion injury by inhibiting monocyte infiltration.

Journal of hepatology·2026
See all related articles

Hepatitis C virus (HCV) infection presents complex challenges, particularly in immunocompromised patients. Protecting at-risk individuals through universal precautions is crucial due to limited treatment efficacy.

Area of Science:

  • Hepatology
  • Virology
  • Infectious Diseases

Background:

  • Hepatitis C virus (HCV) infection exhibits diverse clinical presentations.
  • HCV poses diagnostic and management challenges in specific patient groups like those on hemodialysis or with organ transplants.
  • Co-infection with Hepatitis B virus (HBV) can exacerbate liver disease severity.

Purpose of the Study:

  • To review the multifaceted clinical implications of HCV infection.
  • To highlight diagnostic and therapeutic complexities in vulnerable populations.
  • To emphasize the importance of preventive strategies.

Main Methods:

  • Literature review of clinical manifestations and outcomes of HCV infection.
  • Analysis of challenges in diagnostic assay selection.

Related Experiment Videos

  • Evaluation of treatment efficacy in special patient cohorts.

    • Main Results:

    • HCV infection impacts diagnostic choices, clinical course, and disease severity.
    • Outcomes in organ transplant recipients remain poorly understood.
    • Current antiviral therapies show limited effectiveness in high-risk groups.

    Conclusions:

    • Universal precautionary measures are essential for preventing HCV transmission.
    • Further research is needed to understand long-term HCV consequences in immunocompromised patients.
    • Improved preventive strategies are vital given therapeutic limitations.